수의용 클로스트리디움 백신 시장 규모, 점유율 및 동향 분석 보고서 : 대상 동물별, 대상 병원체별, 질환 유형별, 유형별, 투여 경로별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)

Veterinary Clostridium Vaccine Market Summary

The global veterinary clostridium vaccine market size was valued at USD 422.3 million in 2025 and is projected to grow from USD 447.2 million in 2026 to USD 705.8 million by 2033, at a CAGR of 6.7% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 38.7% in 2025. Key market drivers include the increasing prevalence of clostridial diseases in livestock, growing emphasis on preventive animal healthcare, expansion of commercial livestock production, and rising demand for meat and dairy products.

In addition, government-supported vaccination programs, greater awareness among livestock producers regarding disease prevention, and the adoption of routine herd health management practices are further contributing to the growth of the veterinary clostridium vaccine market.

Market Dynamics

The increasing global production of milk is creating sustained demand for effective livestock health management, thereby supporting the growth of the veterinary clostridium vaccine market. According to the OECD-FAO Agricultural Outlook 2026-2035, global milk production is projected to expand at a CAGR of approximately 2.0% over the next decade, driven primarily by higher milk yields per animal rather than significant herd expansion. Cow milk will continue to account for about 81% of total production, followed by buffalo milk (16%) and milk from goats, sheep, and camels (3%). As dairy producers focus on maximizing productivity from individual animals, maintaining herd health becomes increasingly important. Clostridial diseases such as enterotoxemia and black disease can cause sudden mortality, reduced milk yield, and reproductive losses, leading to significant economic impacts. Thus, preventive vaccination is becoming an integral component of herd health programs to safeguard production efficiency.

Another factor supporting market growth is the increasing implementation of government-led livestock disease prevention programs and regulatory vaccination guidelines. Many countries have strengthened national animal health strategies to reduce the economic burden of clostridial diseases, which can result in sudden livestock mortality and substantial productivity losses. Veterinary authorities are encouraging the adoption of preventive vaccination through disease surveillance initiatives, extension services, and vaccination recommendations for cattle, sheep, goats, and other production animals. Similarly, regulatory agencies continue to apply stringent quality, safety, and efficacy standards for veterinary biologics, improving confidence in commercially available vaccines. These measures promote wider vaccine adoption while encouraging manufacturers to invest in advanced formulations that comply with evolving regulatory requirements.

Global Veterinary Clostridium Vaccine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary clostridium vaccine market report based on species, disease type, targeted pathogen, type, route of administration, distribution channel, and region.

• Species Outlook (Revenue, USD Million, 2021 - 2033)
• Cattle
• Sheep & Goat
• Others
• Targeted Pathogen Outlook (Revenue, USD Million, 2021 - 2033)
• Clostridium perfringens
• Clostridium chauvoei
• Clostridium septicum
• Clostridium tetani
• Others
• Disease Type Outlook (Revenue, USD Million, 2021 - 2033)
• Histotoxic Diseases
• Enteric Diseases
• Neurotoxic Diseases
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Inactivated Toxoid Vaccines
• Inactivated Bacterin Vaccines
• Autogenous Inactivated Vaccines
• Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
• Subcutaneous
• Intramuscular
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Large Commercial Farms
• E-Commerce
• Veterinary Distributors & Wholesalers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Species
  • 1.2.2. Targeted Pathogen
  • 1.2.3. Disease Type
  • 1.2.4. Type
  • 1.2.5. Route of Administration
  • 1.2.6. Distribution Channel
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Bottom-up Approach
  • 1.7.3. Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Incidence of Clostridial Diseases in Livestock
    • 3.2.1.2. Growth in Global Livestock Production and Meat Demand
    • 3.2.1.3. Increasing Focus on Preventive Animal Healthcare and Vaccination Programs
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent Regulatory Requirements for Veterinary Vaccine Approval
    • 3.2.2.2. Limited Vaccine Adoption in Small-Scale and Low-Income Farming Regions
  • 3.2.3. Market Opportunities
  • 3.2.4. Market Challenges
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis, 2025
• 3.5. Tariff & Trade Impact Analysis
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Force Analysis
  • 3.6.2. PESTEL Analysis

Chapter 4. Veterinary Clostridium Vaccine Market: Species Estimates & Trend Analysis

• 4.1. Veterinary Clostridium Vaccine Market, By Species: Segment Dashboard
• 4.2. Veterinary Clostridium Vaccine Market, By Species: Movement Analysis
• 4.3. Veterinary Clostridium Vaccine Market Estimates & Forecasts, By Species, 2021 - 2033 (USD Million)
• 4.4. Cattle
  • 4.4.1. Cattle Market Estimates and Forecasts, 2021 - 2033 (USD million)
• 4.5. Sheep & Goat
  • 4.5.1. Sheep & Goat Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Clostridium Vaccine Market: Targeted Pathogen Estimates & Trend Analysis

• 5.1. Veterinary Clostridium Vaccine Market, By Targeted Pathogen: Segment Dashboard
• 5.2. Veterinary Clostridium Vaccine Market, By Targeted Pathogen: Movement Analysis
• 5.3. Veterinary Clostridium Vaccine Market Estimates & Forecasts, By Targeted Pathogen, 2021 - 2033 (USD Million)
• 5.4. Clostridium perfringens
  • 5.4.1. Clostridium perfringens Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Clostridium chauvoei
  • 5.5.1. Clostridium chauvoei Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Clostridium septicum
  • 5.6.1. Clostridium septicum Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Clostridium tetani
  • 5.7.1. Clostridium tetani Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Clostridium Vaccine Market: Disease Type Estimates & Trend Analysis

• 6.1. Veterinary Clostridium Vaccine Market, By Disease Type: Segment Dashboard
• 6.2. Veterinary Clostridium Vaccine Market, By Disease Type: Movement Analysis
• 6.3. Veterinary Clostridium Vaccine Market Estimates & Forecasts, By Disease Type, 2021 - 2033 (USD Million)
• 6.4. Histotoxic Diseases
  • 6.4.1. Histotoxic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Enteric Diseases
  • 6.5.1. Enteric Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Neurotoxic Diseases
  • 6.6.1. Neurotoxic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Clostridium Vaccine Market: Type Estimates & Trend Analysis

• 7.1. Veterinary Clostridium Vaccine Market, By Type: Segment Dashboard
• 7.2. Veterinary Clostridium Vaccine Market, By Type: Movement Analysis
• 7.3. Veterinary Clostridium Vaccine Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
• 7.4. Inactivated Toxoid Vaccines
  • 7.4.1. Inactivated Toxoid Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Inactivated Bacterin Vaccines
  • 7.5.1. Inactivated Bacterin Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Autogenous Inactivated Vaccines
  • 7.6.1. Autogenous Inactivated Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Clostridium Vaccine Market: Route of Administration Estimates & Trend Analysis

• 8.1. Veterinary Clostridium Vaccine Market, By Route of Administration: Segment Dashboard
• 8.2. Veterinary Clostridium Vaccine Market, By Route of Administration: Movement Analysis
• 8.3. Veterinary Clostridium Vaccine Market Estimates & Forecasts, By Route of Administration, 2021 - 2033 (USD Million)
• 8.4. Subcutaneous
  • 8.4.1. Subcutaneous Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Intramuscular
  • 8.5.1. Intramuscular Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Veterinary Clostridium Vaccine Market: Distribution Channel Estimates & Trend Analysis

• 9.1. Veterinary Clostridium Vaccine Market, By Distribution Channel: Segment Dashboard
• 9.2. Veterinary Clostridium Vaccine Market, By Distribution Channel: Movement Analysis
• 9.3. Veterinary Clostridium Vaccine Market Estimates & Forecasts, By Distribution Channel, 2021 - 2033 (USD Million)
• 9.4. Large Commercial Farms
  • 9.4.1. Large Commercial Farms Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. E-Commerce
  • 9.5.1. E-Commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Veterinary Distributors and Wholesalers
  • 9.6.1. Veterinary Distributors and Wholesalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. Others
  • 9.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Veterinary Clostridium Vaccine Market: Regional Estimates & Trend Analysis

• 10.1. Regional Market Dashboard
• 10.2. Regional Market Share Analysis, 2025 & 2033
• 10.3. North America
  • 10.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.3.2. U.S
    • 10.3.2.1. Key Country Dynamics
    • 10.3.2.2. Competitive Scenario
    • 10.3.2.3. Regulatory Framework
    • 10.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.3.3. Canada
    • 10.3.3.1. Key Country Dynamics
    • 10.3.3.2. Competitive Scenario
    • 10.3.3.3. Regulatory Framework
    • 10.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.3.4. Mexico
    • 10.3.4.1. Key Country Dynamics
    • 10.3.4.2. Competitive Scenario
    • 10.3.4.3. Regulatory Framework
    • 10.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 10.4. Europe
  • 10.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.4.2. UK
    • 10.4.2.1. Key Country Dynamics
    • 10.4.2.2. Competitive Scenario
    • 10.4.2.3. Regulatory Framework
    • 10.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.4.3. Germany
    • 10.4.3.1. Key Country Dynamics
    • 10.4.3.2. Competitive Scenario
    • 10.4.3.3. Regulatory Framework
    • 10.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.4.4. France
    • 10.4.4.1. Key Country Dynamics
    • 10.4.4.2. Competitive Scenario
    • 10.4.4.3. Regulatory Framework
    • 10.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.4.5. Italy
    • 10.4.5.1. Key Country Dynamics
    • 10.4.5.2. Competitive Scenario
    • 10.4.5.3. Regulatory Framework
    • 10.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.4.6. Spain
    • 10.4.6.1. Key Country Dynamics
    • 10.4.6.2. Competitive Scenario
    • 10.4.6.3. Regulatory Framework
    • 10.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.4.7. Denmark
    • 10.4.7.1. Key Country Dynamics
    • 10.4.7.2. Competitive Scenario
    • 10.4.7.3. Regulatory Framework
    • 10.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.4.8. Sweden
    • 10.4.8.1. Key Country Dynamics
    • 10.4.8.2. Competitive Scenario
    • 10.4.8.3. Regulatory Framework
    • 10.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.4.9. Norway
    • 10.4.9.1. Key Country Dynamics
    • 10.4.9.2. Competitive Scenario
    • 10.4.9.3. Regulatory Framework
    • 10.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 10.5. Asia Pacific
  • 10.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.5.2. Japan
    • 10.5.2.1. Key Country Dynamics
    • 10.5.2.2. Competitive Scenario
    • 10.5.2.3. Regulatory Framework
    • 10.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.5.3. China
    • 10.5.3.1. Key Country Dynamics
    • 10.5.3.2. Competitive Scenario
    • 10.5.3.3. Regulatory Framework
    • 10.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.5.4. India
    • 10.5.4.1. Key Country Dynamics
    • 10.5.4.2. Competitive Scenario
    • 10.5.4.3. Regulatory Framework
    • 10.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.5.5. Australia
    • 10.5.5.1. Key Country Dynamics
    • 10.5.5.2. Competitive Scenario
    • 10.5.5.3. Regulatory Framework
    • 10.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.5.6. Thailand
    • 10.5.6.1. Key Country Dynamics
    • 10.5.6.2. Competitive Scenario
    • 10.5.6.3. Regulatory Framework
    • 10.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.5.7. South Korea
    • 10.5.7.1. Key Country Dynamics
    • 10.5.7.2. Competitive Scenario
    • 10.5.7.3. Regulatory Framework
    • 10.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 10.6. Latin America
  • 10.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.6.2. Brazil
    • 10.6.2.1. Key Country Dynamics
    • 10.6.2.2. Competitive Scenario
    • 10.6.2.3. Regulatory Framework
    • 10.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.6.3. Argentina
    • 10.6.3.1. Key Country Dynamics
    • 10.6.3.2. Competitive Scenario
    • 10.6.3.3. Regulatory Framework
    • 10.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 10.7. MEA
  • 10.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.7.2. South Africa
    • 10.7.2.1. Key Country Dynamics
    • 10.7.2.2. Competitive Scenario
    • 10.7.2.3. Regulatory Framework
    • 10.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.7.3. UAE
    • 10.7.3.1. Key Country Dynamics
    • 10.7.3.2. Competitive Scenario
    • 10.7.3.3. Regulatory Framework
    • 10.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.7.4. Saudi Arabia
    • 10.7.4.1. Key Country Dynamics
    • 10.7.4.2. Competitive Scenario
    • 10.7.4.3. Regulatory Framework
    • 10.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.7.5. Kuwait
    • 10.7.5.1. Key Country Dynamics
    • 10.7.5.2. Competitive Scenario
    • 10.7.5.3. Regulatory Framework
    • 10.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.7.6. Qatar
    • 10.7.6.1. Key Country Dynamics
    • 10.7.6.2. Competitive Scenario
    • 10.7.6.3. Regulatory Framework
    • 10.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 10.7.7. Oman
    • 10.7.7.1. Key Country Dynamics
    • 10.7.7.2. Competitive Scenario
    • 10.7.7.3. Regulatory Framework
    • 10.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Key Participant Categorization
  • 11.1.1. Market Leaders
  • 11.1.2. Emerging Players
• 11.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
• 11.3. Company Profiles
  • 11.3.1. Merck & Co., Inc.
    • 11.3.1.1. Company Overview
    • 11.3.1.2. Financial Performance
    • 11.3.1.3. Product Benchmarking
    • 11.3.1.4. Strategic Initiatives
  • 11.3.2. Boehringer Ingelheim Animal Health
    • 11.3.2.1. Company Overview
    • 11.3.2.2. Financial Performance
    • 11.3.2.3. Product Benchmarking
    • 11.3.2.4. Strategic Initiatives
  • 11.3.3. Zoetis
    • 11.3.3.1. Company Overview
    • 11.3.3.2. Financial Performance
    • 11.3.3.3. Product Benchmarking
    • 11.3.3.4. Strategic Initiatives
  • 11.3.4. Elanco
    • 11.3.4.1. Company Overview
    • 11.3.4.2. Financial Performance
    • 11.3.4.3. Product Benchmarking
    • 11.3.4.4. Strategic Initiatives
  • 11.3.5. Virbac
    • 11.3.5.1. Company Overview
    • 11.3.5.2. Financial Performance
    • 11.3.5.3. Product Benchmarking
    • 11.3.5.4. Strategic Initiatives
  • 11.3.6. Ceva
    • 11.3.6.1. Company Overview
    • 11.3.6.2. Financial Performance
    • 11.3.6.3. Product Benchmarking
    • 11.3.6.4. Strategic Initiatives
  • 11.3.7. HIPRA
    • 11.3.7.1. Company Overview
    • 11.3.7.2. Financial Performance
    • 11.3.7.3. Product Benchmarking
    • 11.3.7.4. Strategic Initiatives
  • 11.3.8. Phibro Animal Health Corporation
    • 11.3.8.1. Company Overview
    • 11.3.8.2. Financial Performance
    • 11.3.8.3. Product Benchmarking
    • 11.3.8.4. Strategic Initiatives
  • 11.3.9. Vaxxinova
    • 11.3.9.1. Company Overview
    • 11.3.9.2. Financial Performance
    • 11.3.9.3. Product Benchmarking
    • 11.3.9.4. Strategic Initiatives
  • 11.3.10. Indian Immunologicals Limited.
    • 11.3.10.1. Company Overview
    • 11.3.10.2. Financial Performance
    • 11.3.10.3. Product Benchmarking
    • 11.3.10.4. Strategic Initiatives